6 Best Peptides for Stretch Marks

What to Know Before Choosing a Peptide for Stretch Marks

Stretch marks, known clinically as striae distensae, are a form of dermal scarring. They form when the skin stretches faster than the underlying collagen and elastin network can accommodate, leaving behind disrupted fiber architecture in the dermis. Fresh marks tend to be red or purple and retain some blood supply; older marks fade to white or silver as the tissue becomes more fibrotic. Both respond to the same general biology, but fresh marks are considerably more responsive to treatment.

Peptides sit at the center of most serious conversations about stretch mark improvement because they act directly on the biological targets involved: fibroblasts that produce collagen and elastin, enzymes that degrade that structural scaffolding, and the remodeling process that determines whether new tissue forms in an organized or disordered way. That mechanistic fit is real and well-established. What the literature has not yet delivered, as of 2026, is a large peer-reviewed human clinical trial confirming that any specific peptide formulation reliably reduces stretch marks. The best available evidence from human studies comes from general skin collagen and elasticity research, a handful of small formulation studies, and a substantial body of user experience from people who have run these compounds and reported their results. This guide treats all of that evidence honestly: where human trials exist, they are described as such; where the evidence is user-reported or mechanistic, that is stated plainly.

A peptide earns a slot on this list because people use it or are actively discussing using it for stretch marks. That is the whole test. FDA-compliant cosmetic ingredients, research-only compounds, and everything in between are all eligible, and evidence strength is stated honestly rather than used as a filter that quietly removes the compounds most worth knowing about. The six entries below are ordered by how prominently each compound appears in research and in real-world use, not as a recommendation of one over another. The right compound for any individual depends on factors specific to that person, and that personalized step belongs in the app.

1. GHK-Cu: The Gold Standard for Collagen Rebuilding

GHK-Cu, commonly called copper tripeptide-1, is a naturally occurring tripeptide complexed with a copper ion. It is the compound most people land on first when they start researching peptides for stretch marks, and the research on its skin-relevant mechanisms is genuinely deep compared to most other compounds in this space.

Its primary action in the context of stretch marks is stimulating fibroblasts, the cells responsible for producing collagen and elastin, to increase their output. Cell culture and tissue model studies have shown that GHK-Cu can substantially boost production of collagen I and collagen III, the two structural proteins most disrupted when stretch marks form. It also delivers copper ions to lysyl oxidase, an enzyme that crosslinks newly synthesized collagen fibers into organized, durable tissue rather than the disordered, scar-like material that develops when marks first appear. Beyond that, GHK-Cu appears to shift gene expression in a way that moves tissue from a degradation state toward a repair state, and it reduces the oxidative stress and inflammatory signaling that worsen active marks.

No human clinical trial has been published using GHK-Cu specifically for striae distensae as of 2026. The human evidence base is built from general skin repair research: studies in the anti-aging context show measurable wrinkle depth reduction over eight-week periods, and several 2026 skin peptide review sources rank it as the best-evidenced skin peptide overall based on its collagen-stimulation data. The stretch mark application extrapolates from that general skin-repair evidence, which is a legitimate extrapolation given how directly the mechanisms align, but it is worth being clear that the extrapolation has not been confirmed in a stretch-mark-specific trial.

The user-reported experience for GHK-Cu is the richest of any peptide in this space. Across communities including r/Peptides, r/Biohackers, and r/Mommit, people consistently report results in the range of roughly 50 percent reduction in mark visibility rather than complete elimination. Fresh, red, or purple marks tend to respond more completely; older white marks fade noticeably but rarely disappear entirely. Topical application combined with microneedling is the most frequently cited approach, with the peptide applied immediately after needling to take advantage of enhanced skin penetration. Injectable use is also discussed in biohacker communities, with users reporting somewhat faster results, though injectable GHK-Cu carries the standard risks associated with research-chemical self-administration and is not approved for this use.

For stretch mark purposes, topical GHK-Cu is available in OTC serums and creams and is legally FDA-compliant as a cosmetic ingredient. It is safe for topical use during pregnancy, which gives it a meaningful practical advantage over retinoids, the only other topical approach with consistent evidence behind it for early stretch marks. The evidence here is a mix: mechanistically grounded, supported by general skin-collagen human data, and backed by extensive user-reported experience from people who tracked their own results.

2. Matrixyl: The Formulation Standard for Collagen Signaling

Matrixyl refers to a family of signal peptides built around palmitoylated peptide sequences that instruct fibroblasts to produce more collagen and elastin. The original Matrixyl is palmitoyl pentapeptide-4; Matrixyl 3000 is a formulated combination of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. Both appear frequently in stretch mark discussions, often together, and the distinction matters because they work through complementary mechanisms.

Palmitoyl pentapeptide-4 functions as a matrikine, a molecular fragment that mimics degraded collagen and signals the skin to enter repair mode. Think of it as a fire alarm built from the smoke itself: when your body detects fragments that look like broken-down collagen, it responds by ramping up collagen production. The palmitoyl fatty acid chain attached to the peptide makes it lipophilic, meaning it can cross the outer skin barrier that would otherwise block a hydrophilic molecule from reaching the dermis where it needs to act. Human studies in the anti-aging context show meaningful improvements in wrinkle depth and skin texture. One formulation study combining palmitoyl pentapeptide-4 with a copper peptide reported a substantial reduction in striae depth over 24 weeks, though the peer-review status of that particular study has not been fully confirmed. The Cosmetic Ingredient Review panel reviewed palmitoyl pentapeptide-4 in 2023 and affirmed it as safe for topical use.

Palmitoyl tetrapeptide-7 adds a protective dimension. While the collagen-stimulating peptides are driving new fiber production, palmitoyl tetrapeptide-7 inhibits MMP-1 and MMP-3, which are matrix metalloproteinases, enzymes that degrade collagen during inflammation. The combination of building and protecting simultaneously is part of why Matrixyl 3000 formulations are popular for stretch mark prevention during pregnancy and rapid growth phases, when the marks are still red and the tissue is actively remodeling.

User-reported experience with Matrixyl-based products is less focused than GHK-Cu because Matrixyl appears in so many commercial formulations that people using it for general skin improvement are often not tracking stretch mark outcomes specifically. In stretch mark communities, it is most frequently mentioned as a component of a topical routine alongside GHK-Cu rather than as a standalone approach. It is safe during pregnancy, does not cause photosensitivity, and is generally the best-tolerated option in this space. The evidence is a combination of independent human studies on texture and collagen improvement, one preliminary stretch-mark-specific formulation study, and well-characterized ingredient data from established suppliers.

3. Palmitoyl Tetrapeptide-7: For the Inflammatory Phase

Palmitoyl tetrapeptide-7 appears both as a component of Matrixyl 3000 and on its own in formulations built specifically for stretch mark prevention, particularly in products designed for use during pregnancy. It earns a separate entry here because its mechanism is distinct enough from the collagen-stimulating peptides to be worth understanding on its own terms, and because people specifically seek it out for the inflammatory phase of stretch mark development.

The core action is inhibition of MMP-1 and MMP-3. When skin stretches rapidly and inflammatory signaling increases, these enzymes accelerate the degradation of existing collagen. Stretch marks form in part because breakdown outpaces repair. Palmitoyl tetrapeptide-7 interrupts that process, reducing the destructive side of the equation so collagen-stimulating compounds can gain ground. In formulations containing both palmitoyl tetrapeptide-7 and a collagen-stimulating peptide, the combination is doing two different things at once: building and protecting simultaneously.

The evidence for palmitoyl tetrapeptide-7 is primarily from studies examining it as part of Matrixyl 3000 or within branded ingredient systems like Regestril, a complex combining it with palmitoyl tripeptide-1 and botanical extracts specifically developed for anti-stretch-mark formulations. Standalone published human data on palmitoyl tetrapeptide-7 for striae distensae does not exist as of 2026. The case for it rests on mechanistic logic, its known performance in combination systems, and its established inhibitory effect on the enzymes that drive collagen degradation during inflammation. User-reported experience is mostly embedded in broader reviews of products that contain it alongside other peptides, which makes isolating its specific contribution difficult from community data alone.

Its safety profile is excellent: no irritation, no photosensitivity, and a general tolerability that makes it one of the few options actively recommended for pregnant users who want to address marks as they form rather than after the fact.

4. Heptapeptide-7: For Early-Stage and Active Marks

Heptapeptide-7 is a synthetic seven-amino-acid signal peptide that has been gaining attention in specialized skincare for early-stage stretch marks, meaning the red or purple marks that are still in active inflammation. It sits at the newer end of the peptide landscape and is less widely available than GHK-Cu or Matrixyl, but it shows up in enough stretch-mark-specific discussion to warrant its own entry.

Its mechanism touches several of the repair pathways relevant to stretch marks. It stimulates fibroblasts to produce collagen and elastin, aids in extracellular matrix remodeling by improving the structural scaffold into which new fibers deposit, and encourages keratinocyte migration, which is the movement of skin surface cells toward an area of damage, a process important in wound healing and scar fading. The combination of fibroblast activation and keratinocyte support makes it particularly suited to fresh marks, where the tissue is still biologically active rather than fully fibrotic.

The evidence for heptapeptide-7 is early and primarily generated by formulators and brand developers rather than independent researchers. No large independent human clinical trial has been published specifically for this peptide in stretch marks as of 2026. It is found in niche and specialized skincare formulations rather than mainstream products, and the stretch mark-specific discussion online is relatively limited compared to GHK-Cu or Matrixyl. The case for it is more mechanistic and formulator-driven than user-verified at scale. People who do discuss it tend to be using it early in the stretch mark process, which aligns with where the mechanistic argument is strongest.

One practical note: heptapeptide-7 itself does not cause photosensitivity, but skin that is actively regenerating is more vulnerable to UV damage than healthy intact skin. Anyone using it during or after a stretch mark treatment period should use sun protection on treated areas. It is not a research chemical in the same sense as BPC-157; it circulates primarily through specialized skincare brands, but its availability is narrower than the mainstream palmitoyl peptides.

5. Acetyl Tripeptide-30 Citrulline: For Reducing Mark Visibility

Acetyl tripeptide-30 citrulline is a less commonly discussed peptide that appears in stretch mark research specifically targeting how marks look rather than their underlying structural depth. It has been studied in volunteer testing, with data on reduced stretch mark visibility published in a peer-reviewed journal, which puts it in a different evidentiary position than most of the compounds on this list when it comes to stretch-mark-specific outcomes.

Its mechanism in the stretch mark context centers on improving the appearance and homogeneity of striae distensae, likely through effects on skin texture, pigmentation normalization, and how the surface reflects light. The precise cellular pathway is less thoroughly characterized in the public literature than GHK-Cu or the Matrixyl family, which means the mechanistic story is less complete even though the clinical observation data for visibility reduction is more directly relevant to stretch marks.

Real-world user discussion of acetyl tripeptide-30 citrulline for stretch marks is sparse. It is not a compound people are typically sourcing and running in community protocols the way GHK-Cu is; it is more likely to appear as an ingredient in a commercial formulation someone is evaluating. The evidence sits in a somewhat unusual position: there is published human volunteer data for stretch mark visibility specifically, which is more than most entries on this list can point to for striae distensae, but the community uptake and real-world discussion are limited, so the broader user-experience signal that would confirm practical effectiveness at scale is thinner than for the top entries.

It is a legal cosmetic ingredient, it appears in specialized formulations targeting stretch mark visibility, and the existence of published volunteer data makes it worth knowing about for anyone evaluating formulations or building a research-informed topical routine.

6. BPC-157: The Systemic Healing Argument

BPC-157 is a 15-amino acid synthetic peptide derived from a protective protein found in gastric tissue. It has a well-established reputation in the peptide community for accelerating healing of tendons, ligaments, muscles, and gut tissue, and it shows up in stretch mark discussions primarily in the context of systemic healing stacks rather than as a targeted topical treatment.

The theoretical argument for BPC-157 in stretch marks runs through its broader healing mechanisms: it promotes angiogenesis, the growth of new blood vessels, which is relevant to striae rubra where blood supply is still present; it may upregulate collagen production via fibroblast activation; and its systemic anti-inflammatory properties could theoretically reduce the inflammatory burden that contributes to active stretch mark formation. These mechanisms are real and well-characterized in animal research and in vitro studies. Whether they translate meaningfully to stretch mark improvement in humans has not been tested.

No human clinical trial data has been published for BPC-157 in stretch marks as of 2026. The compound is classified as a research chemical and is not approved for human use outside of clinical trials. Its appearance in stretch mark discussions is almost entirely in biohacker community threads where people are running systemic peptide stacks, often alongside GHK-Cu, and the stretch mark benefit is one of several hoped-for outcomes rather than the primary target. No specific user accounts focused on stretch mark reduction with BPC-157 as the active variable were identified in community research; it typically appears alongside other compounds that have clearer stretch-mark-specific effects.

The evidence here is experiential rather than clinical, and the theoretical rationale is extrapolated from adjacent healing research rather than directly established for striae. For someone specifically targeting stretch marks, BPC-157 is a compound worth understanding as part of the broader conversation, with the caveat that its regulatory status as a research chemical and its lack of human stretch-mark data place it in a different category from the topical cosmetic ingredients above it on this list.

How These Peptides Compare

Frequently Asked Questions

Do peptides actually work for stretch marks, or is this mostly hype?

The mechanistic case is solid, the user-reported results are consistent, and the published human trial data specifically for stretch marks is limited. Peptides like GHK-Cu and Matrixyl work on the exact biology that stretch marks disrupt, which is collagen and elastin production and extracellular matrix repair. People who have used them consistently report meaningful improvement, most commonly around 50 percent reduction in mark visibility rather than full elimination. What does not yet exist is a large peer-reviewed clinical trial confirming efficacy for striae distensae specifically, and that gap is worth knowing about even as the mechanistic and user-experience case for these compounds remains real.

Are stretch mark peptides safe to use during pregnancy?

Topical signal peptides including GHK-Cu, Matrixyl, and palmitoyl tetrapeptide-7 have safety profiles that compare favorably to the alternatives. They do not carry the teratogenicity risk associated with retinoids, which are the only other topical approach with meaningful evidence behind them for early stretch marks but are unsafe during pregnancy. Standard guidance is to consult a healthcare provider before using any topical compound during pregnancy, given that research specifically in pregnant populations is limited. Topical peptides in general show minimal systemic absorption, which is part of why their safety profile is considered reassuring.

How long does it take to see results from peptides on stretch marks?

Based on what people commonly report, meaningful improvement in red or pink marks tends to appear within four to eight weeks of consistent use. Older white marks take longer and respond less completely, with most users describing gradual fading over several months rather than rapid change. The timeline varies depending on the compound, the delivery method, whether techniques like microneedling are used alongside the peptide, and how old the marks are. User-reported experience consistently describes fresh marks as far more responsive than mature ones, which aligns with what the biology of scar tissue predicts.

Can peptides completely remove stretch marks?

Complete removal is rare, based on both community reports and the underlying biology of scar tissue. Most people who use GHK-Cu or Matrixyl-based approaches describe significant fading and texture improvement rather than marks disappearing entirely. Some users with very fresh marks have reported results that look like complete resolution, but this appears to be the exception rather than the rule. Mature white marks with fully fibrotic tissue represent a harder biological problem, and the realistic expectation from peptides is meaningful improvement in appearance rather than elimination.

Do you need a prescription to use these peptides for stretch marks?

GHK-Cu, Matrixyl, palmitoyl tetrapeptide-7, and heptapeptide-7 as topical cosmetic ingredients are available without a prescription in OTC skincare formulations. They are legal cosmetic ingredients under FDA guidelines for topical use. BPC-157 is in a different category: it is classified as a research chemical, is not FDA-approved for human use, and can only be legally sold to qualified researchers. No peptide is currently FDA-approved specifically for treating stretch marks, regardless of how it is obtained.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of peptides for stretch marks in one place.